Functional Tumor Targeting Nano‐Systems for Reprogramming Circulating Tumor Cells with In Situ Evaluation on Therapeutic Efficiency at the Single‐Cell Level
Abstract Tumor heterogeneity is primarily responsible for treatment resistance and cancer relapses. Being critically important to address this issue, the timely evaluation of the appropriateness of therapeutic actions at the single‐cell level is still facing challenges. By using multi‐functionalized...
Main Authors: | Xiao‐He Ren, Xiao‐Yan He, Chang Xu, Di Han, Si‐Xue Cheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-07-01
|
Series: | Advanced Science |
Subjects: | |
Online Access: | https://doi.org/10.1002/advs.202105806 |
Similar Items
-
SpCas9-expression by tumor cells can cause T cell-dependent tumor rejection in immunocompetent mice
by: Reham Ajina, et al.
Published: (2019-05-01) -
Off-target Effects in CRISPR/Cas9-mediated Genome Engineering
by: Xiao-Hui Zhang, et al.
Published: (2015-01-01) -
Research Progress on Nanoparticles-Based CRISPR/Cas9 System for Targeted Therapy of Tumors
by: Dengyun Nie, et al.
Published: (2022-09-01) -
Progress in CRISPR/Cas9 for CAR-T cell therapy of tumors
by: WU Qi, WANG Shaobo
Published: (2023-08-01) -
Optimizing CRISPR Cas9 Genome Editing System: A Review
by: Meen Bahadur Budhthoki, et al.
Published: (2017-03-01)